426 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
SNY Sanofi $43.75 $109.14B Downtrend
Article Searches
Endocyte Reveals Overall Survival Data from TARGET Study http://www.zacks.com/stock/news/189258/endocyte-reveals-overall-survival-data-from-target-study?cid=CS-ZC-FT-189258 Sep 08, 2015 - Endocyte, Inc. (ECYT) announced positive results from the final overall survival analysis from the phase IIb TARGET study on Vynfinit for non-small cell lung cancer.
Regeneron and Sanofi Present Encouraging Praluent Data http://www.zacks.com/stock/news/188756/regeneron-and-sanofi-present-encouraging-praluent-data?cid=CS-ZC-FT-188756 Sep 02, 2015 - Regeneron Pharmaceuticals, Inc. (REGN) and its partner Sanofi (SNY) presented encouraging data from a phase III study on their Praluent, at the ESC Congress 2015.
Sanofi Teams Up with Google Life Sciences for Diabetes http://www.zacks.com/stock/news/188566/sanofi-teams-up-with-google-life-sciences-for-diabetes?cid=CS-ZC-FT-188566 Sep 01, 2015 - Sanofi (SNY) and the life sciences team at Google are collaborating for improving care and outcomes for patients with type I and type II diabetes.
Google, Sanofi to Jointly Improve Diabetes Management http://www.zacks.com/stock/news/188554/google-sanofi-to-jointly-improve-diabetes-management?cid=CS-ZC-FT-188554 Sep 01, 2015 - Given the alarming rise in the diabetic patient population every year, Google Inc.'s (GOOGL) life sciences group has partnered with the French drug maker Sanofi (SNY) to develop tools to enhance holistic diabetes management and treatment worldwide.
Amgen's PCSK9 Inhibitor, Repatha, Approved in the U.S. http://www.zacks.com/stock/news/188143/amgens-pcsk9-inhibitor-repatha-approved-in-the-us?cid=CS-ZC-FT-188143 Aug 28, 2015 - Will FDA approval of Amgen's (AMGN) Repatha trigger a pricing war for this class of treatment?
Oncolytics' Reolysin Phase II Lung Cancer Study Enrolled http://www.zacks.com/stock/news/188033/oncolytics-reolysin-phase-ii-lung-cancer-study-enrolled?cid=CS-ZC-FT-188033 Aug 27, 2015 - Oncolytics Biotech (ONCY) completed enrolling patients in a phase II study on Reolysin for the treatment of non-small cell lung cancer.

Pages: 1...383940414243

<<<Page 43